Quarterly Results

  • Company Name :
Anthem Biosciences Ltd Industry : (Pharmaceuticals)
  • BSE Code:
  • 544449
  • NSE Symbol:
  • ANTHEM
  • P/E(TTM):
  • 65.61
  • ISIN Demat:
  • INE0CZ201020
  • Div & Yield%:
  • 0.00
  • EPS(TTM):
  • 10.68
  • Book Value(₹):
  • 50.80
  • Market Cap(₹Cr.):
  • 39,359.29
  • Face Value(₹):
  • 2.00
Quarters :  
Particulars December 2025 ( Cr)September 2025 ( Cr)June 2025 ( Cr)
Gross Sales 416.58 552.23 538.01
Excise Duty 0.00 0.00 0.00
Net Sales 416.58 552.23 538.01
Other Operating Income 0.00 0.00 0.00
Other Income 39.92 53.80 27.73
Total Income 456.50 606.03 565.74
Total Expenditure 278.51 326.57 342.58
PBIDT 177.98 279.45 223.16
Interest 1.13 2.23 1.61
PBDT 176.86 277.22 221.55
Depreciation 26.75 23.92 22.61
Tax 37.78 63.75 50.07
Fringe Benefit Tax 0.00 0.00 0.00
Deferred Tax 0.21 -8.88 0.53
Reported Profit After Tax 112.12 198.43 148.34
Extra-ordinary Items -18.66 0.00 0.00
Adjusted Profit After Extra-ordinary item 130.78 198.43 148.34
EPS (Unit Curr.) 2.00 3.54 2.65
EPS (Adj) (Unit Curr.) 2.00 3.54 2.65
Calculated EPS (Unit Curr.) 2.00 3.53 2.65
Calculated EPS (Adj) (Unit Curr.) 2.00 3.53 2.65
Calculated EPS (Ann.) (Unit Curr.) 7.99 14.13 10.61
Calculated EPS (Adj) (Ann.) (Unit Curr.) 7.99 14.13 10.61
Book Value (Unit Curr.) 0.00 0.00 0.00
Dividend (%) 0.00 0.00 0.00
Equity 112.32 112.32 111.82
Reserve & Surplus 0.00 0.00 0.00
Face Value 2.00 2.00 2.00
Public Shareholding (No. Of Shares) 0.00 0.00 0.00
Public Shareholding (% in Equity) 0.00 0.00 0.00
Pledged/Encumbered - No. of Shares 0.00 0.00 0.00
Pledged/Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Pledged/Encumbered - % in Total Equity 0.00 0.00 0.00
Non Encumbered - No. of Shares 0.00 0.00 0.00
Non Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Non Encumbered - % in Total Equity 0.00 0.00 0.00
PBIDTM(%) 42.72 50.60 41.48
PBDTM(%) 42.46 50.20 41.18
PATM(%) 26.91 35.93 27.57